<DOC>
	<DOCNO>NCT00820794</DOCNO>
	<brief_summary>The purpose study investigate PD 0332334 affect pharmacokinetics lithium co-administering drug healthy adult .</brief_summary>
	<brief_title>A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects</brief_title>
	<detailed_description>Additional Study Purpose Details : To investigate potential drug-drug interaction PD 0332334 lithium</detailed_description>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Healthy male and/or female Age 21 55 ( inclusive ) BMI range 18 30 kg/m2 Previous participation PD 332334 study Pregnant nursing female Hypersensitivity ( allergic ) lithium , Neurontin ( gabapentin ) , Lyrica ( pregabalin )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Drug-drug interaction , lithium , PD 0332334 , pharmacokinetics</keyword>
</DOC>